L-Arginine in coronary atherosclerosis

Area of Science:

• Biochemistry
• Cardiovascular Physiology
• Medical Science

Background:

• Nitric oxide (NO) is synthesized from L-arginine by nitric oxide synthase (NOS) enzymes.
• Endothelium-dependent vasodilation is crucial for maintaining vascular health.
• Hypercholesterolemia can impair endothelial function and contribute to atherosclerosis.

Purpose of the Study:

• To investigate the effects of L-arginine administration on coronary vasodilation in patients with normal and diseased coronary arteries.
• To assess the potential of L-arginine in reversing endothelial dysfunction associated with hypercholesterolemia.
• To explore the role of nitric oxide generation in inhibiting atherogenesis and post-angioplasty lesion formation.

Main Methods:

• Administration of L-arginine to patients.
• Measurement of coronary blood flow response to acetylcholine.
• Evaluation of endothelium-dependent vasodilation.
• Assessment of lesion formation after balloon angioplasty.

Main Results:

• L-arginine improved coronary blood flow response to acetylcholine in patients with normal arteries and hypercholesterolemia.
• L-arginine reversed defective endothelium-dependent vasodilation linked to elevated low-density lipoprotein (LDL) levels.
• L-arginine dilated coronary arteries and stenoses, enhanced nitric oxide generation, and inhibited lesion formation post-angioplasty.

Conclusions:

• L-arginine administration is beneficial for improving endothelial function and coronary vasodilation.
• Stimulating endogenous nitric oxide production via L-arginine may inhibit atherogenesis.
• L-arginine holds therapeutic potential for patients with atherosclerosis risk factors.